يعرض 1 - 20 نتائج من 483 نتيجة بحث عن '"aspirin-exacerbated respiratory disease"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 7 (2023); 203-208 ; Медицинский Совет; № 7 (2023); 203-208 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/7527/6711; Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(29):1–464. https://doi.org/10.4193/rhin20.600.; Stevens W.W., Schleimer R.P., Kern R.C. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2016;4(4):565–572. https://doi.org/10.1016/j.jaip.2016.04.012.; Bhattacharyya N., Gilani S. Prevalence of Potential Adult Chronic Rhinosinusitis Symptoms in the United States. Otolaryngol Head Neck Surg. 2018;159(3):522–525. https://doi.org/10.1177/0194599818774006.; De Loos D.D., Lourijsen E.S., Wildeman M.A.M., Freling N.J.M., Wolvers M.D.J., Reitsma S., Fokkens W.J. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J Allergy Clin Immunol. 2019;143(3):1207–1214. https://doi.org/10.1016/j.jaci.2018.12.986.; Носуля Е.В., Ким И.А., Афанасьева Н.В., Сумбаева О.В. Распространенность полипозного риносинусита среди городского населения Восточной Сибири. Российская ринология. 2007;(1):4–8. Режим доступа: https://elibrary.ru/item.asp?id=9488947.; Larsen K., Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol. 2002;122(2):179–182. https://doi.org/10.1080/00016480252814199.; Larsen P.L., Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope. 2004;114(4):710–719. https://doi.org/10.1097/00005537-200404000-00022.; Bhattacharyya N., Villeneuve S., Joish V.N., Amand C., Mannent L., Amin N. et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969–1975. https://doi.org/10.1002/lary.27852.; Wynn T.A. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271–282. https://doi.org/10.1038/nri3831.; Gieseck R.L., Wilson M.S., Wynn T.A. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18(1):62–76. https://doi.org/10.1038/nri.2017.90.; Davies A.M., Allan E.G., Keeble A.H., Delgado J., Cossins B.P., Mitropoulou A.N. et al. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. J Biol Chem. 2017;292(24):9975–9987. https://doi.org/10.1074/jbc.m117.776476.; Stevens W.W., Peters A.T., Tan B.K., Klingler A.I., Poposki J.A., Hulse K.E. et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812–2820. e3. https://doi.org/10.1016/j.jaip.2019.05.009.; Busse W.W., Kraft M., Rabe K.F., Deniz Y., Rowe P.J., Ruddy M., Castro M. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J. 2021;58(2):2003393. https://doi.org/10.1183/13993003.03393-2020.; Belmesk L., Muntyanu A., Cantin E., AlHalees Z., Jack C.S., Le M. et al. Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. J Cutan Med Surg. 2022;26(1):33–49. https://doi.org/10.1177/12034754211027858.; Moyle M., Cevikbas F., Harden J.L., Guttman-Yassky E. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches. Exp Dermatol. 2019;28(7):756–768. https://doi.org/10.1111/exd.13911.; Dellon E.S., Spergel J.M. Biologics in eosinophilic gastrointestinal diseases. Ann Allergy Asthma Immunol. 2023;130(1):21–27. https://doi.org/10.1016/j.anai.2022.06.015.; Lourijsen E.S., Reitsma S., Vleming M., Hannink G., Adriaensen G.F.J.P.M., Cornet M.E. et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med. 2022;10(4):337–346. https://doi.org/10.1016/s2213-2600(21)00457-4.; Bakakos A., Schleich F., Bakakos P. Biological Therapy of Severe Asthma and Nasal Polyps. J Pers Med. 2022;12(6):976. https://doi.org/10.3390/jpm12060976.; Virkkula P., Penttilä E., Vento S.I., Myller J., Koskinen A., Hammarén-Malmi S. et al. Assessing Cut-off Points of Eosinophils, Nasal Polyp, and Lund-Mackay Scores to Predict Surgery in Nasal Polyposis: A Real-World Study. Allergy Rhinol (Providence). 2020;11:215265672095659. https://doi.org/10.1177/2152656720956596.; Lee S.E., Hopkins C., Mullol J., Msihid J., Guillemin I., Amin N. et al. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies. Allergy. 2022;77(7):2211–2221. https://doi.org/10.1111/all.15222.; Hopkins C., Buchheit K.M., Heffler E., Cohen N.A., Olze H., Khan A.H. et al. Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study. J Asthma Allergy. 2022;15:767–773. https://doi.org/10.2147/jaa.s363527.; Bachert C., Han J.K., Desrosiers M., Hellings P.W., Amin N., Lee S.E. et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–1650. https://doi.org/10.1016/s0140-6736(19)31881-1.; Caminati M., Olivieri B., Dama A., Micheletto C., Paggiaro P., Pinter P. et al. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management. Expert Rev Respir Med. 2022;16(7):713–721. https://doi.org/10.1080/17476348.2022.2090342.; Olaguibel J.M., Sastre J., Rodríguez J.M., del Pozo V. Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes. J Investig Allergol Clin Immunol. 2022;32(3):165–180. https://doi.org/10.18176/jiaci.0823.; Barthel S.R., Johansson M.W., McNamee D.M., Mosher D.F. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol. 2008;83(1):1–12. https://doi.org/10.1189/jlb.0607344.; Wechsler M.E., Klion A.D., Paggiaro P., Nair P., Staumont-Salle D., Radwan A. et al. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2022;10(10):2695–2709. https://doi.org/10.1016/j.jaip.2022.05.019.; Menzella F., Montanari G., Patricelli G., Cavazza A., Galeone C., Ruggiero P. et al. A case of chronic eosinophilic pneumonia in a patient treated with dupilumab. Ther Clin Risk Manag. 2019;15:869–875. https://doi.org/10.2147/tcrm.s207402.; Iwamuro M., Murakami T., Tanaka T., Oka S., Kawano S., Kawahara Y., Okada H. Eosinophilic Gastritis in a Patient Previously Treated with Dupilumab. Case Rep Gastrointest Med. 2020;2020:6381670. https://doi.org/10.1155/2020/6381670.; Descamps V., Deschamps L., El Khalifa J., Groh M., Gibier J.B., Lefèvre G., Taillé C. Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma. Respir Med Res. 2021;79:100821. https://doi.org/10.1016/j.resmer.2021.100821.; Eger K., Pet L., Weersink E.J.M., Bel E.H. Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma. J Allergy Clin Immunol Pract. 2021;9(7):2913–2915. https://doi.org/10.1016/j.jaip.2021.02.042.; Pavord I.D., Hanania N.A., Corren J. Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2022;10(2):410–419. https://doi.org/10.1016/j.jaip.2021.12.014.; https://www.med-sovet.pro/jour/article/view/7527

  20. 20
    Academic Journal